{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:43:42Z","timestamp":1759412622989},"reference-count":26,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.05.087","type":"journal-article","created":{"date-parts":[[2008,6,24]],"date-time":"2008-06-24T14:29:15Z","timestamp":1214317755000},"page":"4602-4607","source":"Crossref","is-referenced-by-count":12,"title":["A clinical trial examining the effect of increased total CRM197 carrier protein dose on the antibody response to Haemophilus influenzae type b CRM197 conjugate vaccine"],"prefix":"10.1016","volume":"26","author":[{"given":"Vytautas","family":"Usonis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vytautas","family":"Bakasenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherryl","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Laudat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2008.05.087_bib1","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1097\/00006454-199809001-00008","article-title":"Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada","volume":"17","author":"Wenger","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"18","key":"10.1016\/j.vaccine.2008.05.087_bib2","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.05.087_bib3","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.087_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.087_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"issue":"14","key":"10.1016\/j.vaccine.2008.05.087_bib6","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jama.293.14.1751","article-title":"Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial","volume":"293","author":"Buttery","year":"2005","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.05.087_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(90)90264-V","article-title":"An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay","volume":"135","author":"Phipps","year":"1990","journal-title":"J Immunol Methods"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.087_bib8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CDLI.10.4.514-519.2003","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.087_bib9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/CDLI.7.5.764-768.2000","article-title":"Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines","volume":"7","author":"Sikkema","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2008.05.087_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM198710083171503","article-title":"Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin","volume":"317","author":"Santosham","year":"1987","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.087_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"147","author":"Kayhty","year":"1983","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2008.05.087_bib12","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2008.05.087_bib13","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"unstructured":"World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series, No. 927; 2005.","key":"10.1016\/j.vaccine.2008.05.087_bib14"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.087_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00003495-199855030-00003","article-title":"Meningococcal vaccines","volume":"55","author":"Peltola","year":"1998","journal-title":"Drugs"},{"year":"1994","author":"Efstratiou","series-title":"Laboratory diagnosis of diphtheria, expanded programme on immunization in the european region","key":"10.1016\/j.vaccine.2008.05.087_bib16"},{"key":"10.1016\/j.vaccine.2008.05.087_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4049\/jimmunol.54.4.325","article-title":"Circulating antitoxin at the onset of diphtheria in 425 patients","volume":"54","author":"Ipsen","year":"1946","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.05.087_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00365548609032332","article-title":"Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics","volume":"18","author":"Bj\u00f6rkholm","year":"1986","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.05.087_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM196401232700404","article-title":"The prophylactic dose of homologous tetanus antitoxin","volume":"270","author":"McComb","year":"1964","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.087_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5694\/j.1326-5377.1976.tb130113.x","article-title":"Problems in the immunology and control of tetanus","volume":"2","author":"Edsall","year":"1976","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.087_bib21","first-page":"683","article-title":"Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids","volume":"32","author":"MacLennan","year":"1965","journal-title":"Bull World Health Organ"},{"issue":"6 Suppl.","key":"10.1016\/j.vaccine.2008.05.087_bib22","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1097\/01.inf.0000166157.21561.78","article-title":"Acellular pertussis vaccines for adolescents","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.087_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.087_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00006454-200102000-00007","article-title":"Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants","volume":"20","author":"Rennels","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2008.05.087_bib25","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(00)00241-3","article-title":"A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants","volume":"19","author":"English","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.087_bib26","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08006828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08006828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:33:21Z","timestamp":1684452801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08006828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":26,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0264410X08006828"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}